Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02857816 · ClinicalTrials.gov registry record · NA
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
A NA study of Overactive Bladder, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 11
- Study locations
NCT02857816: Completed NA study of Overactive Bladder, sponsored by MedtronicNeuro.
NCT02857816 is a NA study of Overactive Bladder that has completed, run by MedtronicNeuro. The registered enrollment target is 154 participants, below the 204-participant average among 46 other Overactive Bladder trials with a reported enrollment target (25% lower). The trial reports 11 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02857816, a NA study of Overactive Bladder, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 11
- Study locations
Study Summary
To evaluate the NURO system for the treatment of OAB in drug naïve patients.
Primary Outcome
Number of UUI episodes were collected at baseline and following the 12th PTNM therapy session. For each subject in the analysis, change in UUI episodes per day was calculated as UUI episodes per day after 12th PTNM session minus baseline. A negative change indicates the improvement in UUI symptom.
Conditions Studied
Interventions
- DEVICE NURO System PTNM Therapy
Study Locations (11)
Florida
- Pinellas Urology, Inc. - St. Petersburg
Illinois
- NorthShore University Health System - Evanston
Massachusetts
- Mount Auburn Hospital - Cambridge
Michigan
- Advanced Urogynecology of Michigan, P.C. - Dearborn
Minnesota
- Metro Urology - Woodbury
New Jersey
- Urology Center Research Institute, LLC - Englewood
New York
- NYU Urology Associates - New York
North Carolina
- Alliance Urology Specialists - Greensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-11-21 |
| Phase | NA |
What the finished NCT02857816 record still lists
NCT02857816 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 204-participant average among 46 other Overactive Bladder trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which NURO System PTNM Therapy is the first listed.
NCT02857816 lists 11 locations in 11 states (Florida, Illinois, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02857816 about?
NCT02857816 is a clinical study titled "PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB". To evaluate the NURO system for the treatment of OAB in drug naïve patients.
What is the current status of trial NCT02857816?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2016-09. Estimated completion is 2017-11-21.
What conditions does trial NCT02857816 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT02857816?
The interventions under investigation include: NURO System PTNM Therapy (DEVICE).
Who is sponsoring clinical trial NCT02857816?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02857816 being conducted?
This trial has 11 study locations across Florida, Illinois, Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02857816's enrollment target sits among peer trials
154 18th of 46 higher than 29 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia